Article
Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets.
International journal of immunopathology and pharmacology - 1 Jan 2026
Zhang Han, Dang Zixian, Yu Pixue, Chen GuanHong, Zhang Yingze, Wang Tianrui, Yu Tengbo, Zhang Yongtao, Shang Zhen
Abstract excerpt
OBJECTIVE: To explore whether circulating plasma proteins have potential causal effects on gout risk by integrating genome-wide association study (GWAS) data with protein quantitative trait loci (pQTL) information, aiming to identify candidate proteins and pathways for therapeutic targeting. INTRODUCTION: Despite advances in gout pathophysiology, personalized therapies and validated drug targets remain limited....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
